CHE

Chemed Corp. (CHE) Q3 2025 Filing Summary

Business Context and Reporting Period

This summary covers Chemed Corporation's Form 10-Q for the quarterly period ended September 30, 2025. Chemed operates through two primary segments: VITAS Healthcare (hospice care) and Roto-Rooter (plumbing, drain cleaning, and water restoration). The company is a large accelerated filer incorporated in Delaware.

Key Financial Metrics

Note: Adjusted metrics are non-GAAP measures reconciled in the filing.

Material Changes vs. Prior Period

• Revenue Growth: Consolidated revenue increased 3.1% in Q3 and 5.5% for the nine months ended Sept 30, 2025.
  • VITAS: Revenue grew 4.2% in Q3 (driven by a 2.5% increase in days-of-care and a 4.1% Medicare rate increase) and 8.2% for the nine months. Growth was partially offset by a 121-basis point negative impact from acuity mix shifts and a 124-basis point reduction due to Medicare cap adjustments.
  • Roto-Rooter: Revenue grew 1.1% in Q3 and 1.2% for the nine months. Growth in excavation and water restoration was offset by declines in drain cleaning and plumbing job counts.
• Profitability Decline: Net income decreased 15.2% in Q3 and 11.0% for the nine months compared to the prior year.
  • Gross Margins: Consolidated gross margin declined to 31.5% in Q3 (from 34.6% in Q3 2024) and 31.6% for the nine months (from 34.6%). VITAS margins were pressured by a $3.8M increase in Medicare Cap liability in Q3 and $18.8M for the nine months, alongside higher variable patient care expenses. Roto-Rooter margins declined due to increased variable expenses and a $5.8M rise in casualty insurance expense for the nine months.
• Balance Sheet: Accounts receivable increased $44.4M due to payment timing. "Other assets" decreased $47.6M primarily due to the refund of a $46.9M deposit related to a resolved OAS audit (see Legal Matters).

Guidance, Outlook, and Risks

• Capital Allocation: The company remains aggressive on share buybacks. In Q3 2025, it repurchased 407,500 shares for $180.8M. The Board authorized an additional $300M in August 2025, leaving $301.8M remaining under the program. Dividends were increased to $0.60 per share in Q3 (from $0.50 in Q3 2024).
• Macroeconomic Outlook: Management monitors inflation and tariffs but does not expect a material negative effect on 2025 results. They are evaluating potential cost increases for 2026 planning.
• Cybersecurity Incident (Critical): On October 24, 2025, VITAS detected a cyber intrusion by a third-party vendor. Protected Health Information (PHI) was viewed, and a threat actor claimed to have accessed data, demanding payment. VITAS has contained the incident, notified law enforcement, and believes operations and financial systems are not materially affected, though the full scope is under investigation.
• Legal Resolution: A significant regulatory matter regarding a $140M OAS audit recommendation was largely resolved in March 2025. An Administrative Law Judge ruled in VITAS's favor, resulting in the refund of the $50.3M deposit previously held.

Investor Verification Checklist

• Cyber Incident Impact: Monitor updates on the October 2025 VITAS data breach to assess potential regulatory fines, litigation costs, and reputational damage.
• Medicare Cap Liability: Verify the trajectory of the Medicare Cap liability, which significantly impacted VITAS margins in 2025 ($18.8M for 9M).
• Roto-Rooter Job Counts: Track the decline in drain cleaning and plumbing job counts to determine if this is a temporary trend or a structural shift in demand.
• Share Repurchase Pace: Confirm the utilization of the remaining $301.8M buyback authorization and its impact on future EPS.
• Insurance Costs: Review the $5.8M increase in casualty insurance expense for Roto-Rooter to understand if this is a one-time adjustment or a recurring cost increase.